Novigenix is a precision medicine company specializing in AI-RNA analytics, offering ImmunoTranscriptomic solutions for disease detection, novel therapeutic development, and improved patient outcomes. Our proprietary platform is tailored for whole blood RNA biomarkers, and mapping the response of the immune system to progression of disease and therapeutic modalities. The platform efficiently integrates patient multi-omics data, and advanced artificial intelligence approaches to provide actionable insights and precision solutions for optimization of patient’s therapeutic journey. Novigenix is the leading partner of choice for Pharma and Biotech to leverage RNA analytics and generate previously unknown insights into patient disease states and response to therapy. Our product pipeline includes patient stratification solutions in the field of Immuno-Oncology and therapy optimization solutions for management of cancer patients.